Erudio Healtherudio.com
Drug
datopotamab deruxtecan
1 HCP commentary report on clinical trials studying datopotamab deruxtecan. Each report covers what clinicians said in public about one trial, with the source behind every view.
| Trial | Indication | Phase | Statements | HCP sources | Size | Updated | Preview |
|---|---|---|---|---|---|---|---|
| ICARUS-LUNG01 NCT04940325 · Gustave Roussy, Cancer Campus, Grand Paris | advanced and/or unresectable non-small cell lung cancer | Phase 2 | 59 | 25 | Focused | Oct 31, 2026 | Preview |